Literature DB >> 22385431

Myositis due to the microsporidian Anncaliia (Brachiola) algerae in a lung transplant recipient.

A S Field1, J Y Paik, D Stark, M R Qiu, A Morey, M L Plit, E U Canning, A R Glanville.   

Abstract

Microsporidia are obligate intracellular parasites, more closely related to fungi than protozoa on molecular phylogenetic analysis, and are known to be a rare cause of opportunistic infection in immune compromised patients including human immunodeficiency virus-positive patients and solid organ transplant recipients. We report the first case to our knowledge of microsporidial myositis in a lung transplant recipient. He was 49 years old and had received a lung transplant in 2000 for cystic fibrosis. He presented in 2009 with fevers, chronic diarrhea, myalgia, and pancytopenia, and developed progressive weakness and neurological symptoms before his death 35 days after hospital admission. Multiple investigations, including stool culture, rectal biopsy, colonoscopy, cerebrospinal fluid examination, bone marrow biopsy, lung biopsy, and bronchoalveolar lavage, failed to reveal a definite cause for the patient's deterioration. The diagnosis of microsporidial infection was made on post-mortem light microscopic examination of tissue sections of the tongue and deltoid muscle. Light microscopy diagnosed a microsporidial myositis, confirmed by transmission electron microscopy, which suggested that the organism was Brachiola species. The identity of the organism was confirmed by polymerase chain reaction as Brachiola algerae (recently renamed Anncaliia algerae). The case highlights the need to consider protozoal organisms in the differential diagnosis of myalgia and multisystemic infections in immune compromised patients.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22385431     DOI: 10.1111/j.1399-3062.2012.00724.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  12 in total

Review 1.  Laboratory Diagnosis of Parasites from the Gastrointestinal Tract.

Authors:  Lynne S Garcia; Michael Arrowood; Evelyne Kokoskin; Graeme P Paltridge; Dylan R Pillai; Gary W Procop; Norbert Ryan; Robyn Y Shimizu; Govinda Visvesvara
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

2.  Analysis of the beta-tubulin gene and morphological changes of the microsporidium Anncaliia algerae both suggest albendazole sensitivity.

Authors:  Marianita Santiana; Cyrilla Pau; Peter M Takvorian; Ann Cali
Journal:  J Eukaryot Microbiol       Date:  2014-09-15       Impact factor: 3.346

Review 3.  Therapeutic targets for the treatment of microsporidiosis in humans.

Authors:  Bing Han; Louis M Weiss
Journal:  Expert Opin Ther Targets       Date:  2018-11-01       Impact factor: 6.902

4.  Successful Treatment of Disseminated Anncaliia algerae Microsporidial Infection With Combination Fumagillin and Albendazole.

Authors:  Mélissa Boileau; José Ferreira; Imran Ahmad; Christian Lavallée; Yvonne Qvarnstrom; Simon F Dufresne
Journal:  Open Forum Infect Dis       Date:  2016-07-29       Impact factor: 3.835

Review 5.  Solid Organ Transplant and Parasitic Diseases: A Review of the Clinical Cases in the Last Two Decades.

Authors:  Silvia Fabiani; Simona Fortunato; Fabrizio Bruschi
Journal:  Pathogens       Date:  2018-07-31

Review 6.  Secondary myopathy due to systemic diseases.

Authors:  J Finsterer; W N Löscher; J Wanschitz; S Quasthoff; W Grisold
Journal:  Acta Neurol Scand       Date:  2016-02-25       Impact factor: 3.209

Review 7.  Microsporidial myositis in adult-onset immunodeficiency: case-based review.

Authors:  T G Sundaram; Amita Aggarwal; Sujata Ganguly; Elgiva Khristie Iangngap; Rungmei S K Marak; Latika Gupta
Journal:  Rheumatol Int       Date:  2019-09-09       Impact factor: 3.580

8.  Cutaneous microsporidiosis in an immunosuppressed patient.

Authors:  Daniel A Nadelman; Ashley R Bradt; Yvonne Qvarnstrom; Cynthia S Goldsmith; Sherif R Zaki; Frank Wang; Emily H Smith; Douglas R Fullen
Journal:  J Cutan Pathol       Date:  2020-03-20       Impact factor: 1.458

9.  Anncaliia algerae microsporidial myositis.

Authors:  Matthew R Watts; Renee C F Chan; Elaine Y L Cheong; Susan Brammah; Kate R Clezy; Chiwai Tong; Deborah Marriott; Cameron E Webb; Bobby Chacko; Vivienne Tobias; Alexander C Outhred; Andrew S Field; Michael V Prowse; James V Bertouch; Damien Stark; Stephen W Reddel
Journal:  Emerg Infect Dis       Date:  2014-02       Impact factor: 6.883

10.  Anncaliia algerae Microsporidial Myositis, New South Wales, Australia.

Authors:  Gaurav Sutrave; Adam Maundrell; Caitlin Keighley; Zoe Jennings; Susan Brammah; Min-Xia Wang; Roger Pamphlett; Cameron E Webb; Damien Stark; Helen Englert; David Gottlieb; Ian Bilmon; Matthew R Watts
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.